Literature DB >> 8295657

Beta-amyloid accumulation in aged canine brain: a model of early plaque formation in Alzheimer's disease.

B J Cummings1, J H Su, C W Cotman, R White, M J Russell.   

Abstract

We characterized eight aged beagles (maintained from birth in a laboratory colony) and one black Labrador using Bielschowsky's, thioflavine S, and Congo red staining, and antibodies to the beta-amyloid peptide, dystrophic neurites, and other plaque components. All plaques within these canine brains were of the diffuse subtype and were neither thioflavine S- nor Congo red-positive. The majority of plaques in the entorhinal cortex contained numerous neurons within them while plaques in the dentate gyrus did not. beta-Amyloid immunoreactivity was also present within select neurons and neuronal processes and was detected as a diffuse linear zone corresponding to the terminal fields of the perforant path. There was no significant correlation between extent of beta-amyloid accumulation and neuron number in entorhinal cortex. Neither tau-1, PHF-1, nor SMI-31-immunostaining revealed dystrophic fibers, confirming the classification of these plaques as diffuse. Canine plaques did not appear to contain bFGF- or HS-positive immunostaining. This may explain why neuritic involvement was not detected within these canine plaques. It is possible that the beta-amyloid within the canine brain has a unique primary structure or may not be in an assembly state that adversely affects neurons.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8295657     DOI: 10.1016/0197-4580(93)90038-d

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  37 in total

1.  Microglia in Alzheimer's disease and transgenic models. How close the fit?

Authors:  D W Dickson
Journal:  Am J Pathol       Date:  1999-06       Impact factor: 4.307

2.  Adenosine 3',5'-cyclic monophosphate increases processing of amyloid precursor protein (APP) to beta-amyloid in neuroblastoma cells without changing APP levels or expression of APP mRNA.

Authors:  A Kumar; F G La Rosa; A R Hovland; W C Cole; J Edwards-Prasad; K N Prasad
Journal:  Neurochem Res       Date:  1999-10       Impact factor: 3.996

3.  BDNF increases with behavioral enrichment and an antioxidant diet in the aged dog.

Authors:  Margaret Fahnestock; Monica Marchese; Elizabeth Head; Viorela Pop; Bernadeta Michalski; William N Milgram; Carl W Cotman
Journal:  Neurobiol Aging       Date:  2010-05-05       Impact factor: 4.673

Review 4.  Animal models in the drug discovery pipeline for Alzheimer's disease.

Authors:  Debby Van Dam; Peter Paul De Deyn
Journal:  Br J Pharmacol       Date:  2011-10       Impact factor: 8.739

5.  The benefits and limitations of animal models for translational research in neurodegenerative diseases.

Authors:  Mathias Jucker
Journal:  Nat Med       Date:  2010-09-21       Impact factor: 53.440

Review 6.  A potential role for apoptosis in neurodegeneration and Alzheimer's disease.

Authors:  C W Cotman; A J Anderson
Journal:  Mol Neurobiol       Date:  1995-02       Impact factor: 5.590

Review 7.  A canine model of human aging and Alzheimer's disease.

Authors:  Elizabeth Head
Journal:  Biochim Biophys Acta       Date:  2013-03-23

8.  A combination cocktail improves spatial attention in a canine model of human aging and Alzheimer's disease.

Authors:  Elizabeth Head; Heather L Murphey; Amy L S Dowling; Katie L McCarty; Samuel R Bethel; Jonathan A Nitz; Melanie Pleiss; Jenna Vanrooyen; Mike Grossheim; Jeffery R Smiley; M Paul Murphy; Tina L Beckett; Dieter Pagani; Frederick Bresch; Curt Hendrix
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

9.  Strategies for improving cognition with aging: insights from a longitudinal study of antioxidant and behavioral enrichment in canines.

Authors:  Lori-Ann Christie; Wycliffe O Opii; Elizabeth Head
Journal:  Age (Dordr)       Date:  2008-06-22

10.  Diminished perisomatic GABAergic terminals on cortical neurons adjacent to amyloid plaques.

Authors:  Virginia Garcia-Marin; Lidia Blazquez-Llorca; José-Rodrigo Rodriguez; Susana Boluda; Gerard Muntane; Isidro Ferrer; Javier Defelipe
Journal:  Front Neuroanat       Date:  2009-11-20       Impact factor: 3.856

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.